[1] ZHENG RS,ZHANG SW,ZENG HM,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.
[2] GAO SG,LI N,WANG SH,et al.Lung cancer in People's Republic of China[J].J Thorac Oncol,2020,15(10):1567-1576.
[3] SUN AQ,JU XL.Advances in research on anticancer properties of salidroside[J].Chin J Integr Med,2021,27(2):153-160.
[4] ZHAO Z,SUN W,GUO ZY,et al.Mechanisms of lncRNA/microRNA interactions in angiogenesis[J].Life Sci,2020,254:116900.
[5] PAN WM,WANG H,ZHANG XF,et al.miR-210 participates in hepatic ischemia reperfusion injuryby forming a negative feedback loop with SMAD4[J].Hepatolog,2020,72(6):2134-2148.
[6] SHAN H,LI XH,OUYANG C,et al.Salidroside prevents PM2.5-induced BEAS-2B cell apoptosis via SIRT1-dependent regulation of ROS and mitochondrial function[J].Ecotoxicol Environ Saf,2022,231:113170.
[7] ZHANG XM,XIE L,LONG JY,et al.Salidroside:A review of its recent advances in synthetic pathways and pharmacological properties[J].Chem Biol Interact,2021,339:109268.
[8] SUN SY,TUO QH,LI DX,et al.Antioxidant effects of salidroside in the cardiovascular system[J].Evid Based Complement Alternat Med,2020,2020:9568647.
[9] ALI SYEDA Z,LANGDEN SSS,MUNKHZUL C,et al.Regulatory mechanism of microRNA expression in cancer[J].Int J Mol Sci,2020,21(5):1723-1741.
[10] BAVELLONIi A,RAMAZZOTTI G,POLI A,et al.MiRNA-210:A current overview[J].Anticancer Research,2017,37(12):6511-6521.
[11] ZHANG HX,WU J,WU JH,et al.Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice[J].Journal of Nanobiotechnology,2019,17(1):29-52.
[12] GROSSO S,DOYEN J,PARKS SK,et al.MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines[J].Cell Death & Disease,2013,4:e544.
[13] LIU D,XIA H,WANG F,et al.MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer[J].OncoTargets and Therapy,2016,9:5245-5255.
[14] XIE D,PEI Q,LI JY,et al.Emerging role of E2F family in cancer stem cells[J].Front Oncol,2021,11:723137.
[15] FENG ZC,PENG C,LI DJ,et al.E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma[J].OncoTargets and Therapy,2018:11:5303-5313.
[16] SUN FB,LIN Y,LI SJ,et al.MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression[J].European Review for Medical and Pharmacological Sciences,2018,22(24):8640-8648.
[17] JIN Y,WEI J,XU ST,et al.miR-210-3pregulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3[J].Molecular Medicine Reports,2019,19(6):4946-4954.
[18] HUANG LT,HUANG ZX,LIN WJ,et al.Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway[J].Int J Oncol,2019,54(6):1969-1980.
[19] DING SY,WAGN MT,DAI DF,et al.Salidroside induces apoptosis and triggers endoplasmic reticulum stress in human hepatocellular carcinoma[J].Biochem Biophys Res Commun,2020,527(4):1057-1063.
[20] ZHANG X,ZHU JL,YAN JN,et al.Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L.for non-small cell lung cancer[J].Phytomedicine,2020,79:153326.
[21] ZHANG ZD,YANG W,MA F,et al.Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis[J].Drug Deliv,2020,27(1):691-702.